Hajduch E, Hainault I, Meunier C, Jardel C, Hainque B, Guerre-Millo M, Lavau M
INSERM U-177, Institut Biomédical des Cordeliers, Paris, France.
Endocrinology. 1995 Nov;136(11):4782-9. doi: 10.1210/endo.136.11.7588207.
A triggering effect of insulin on GLUT4 expression in adipocytes is consistently observed in vivo, whereas GLUT1 is roughly unaffected. However, in cultured rat adipocytes, insulin increases GLUT1 but fails to increase GLUT4, suggesting that additional factors are involved in vivo. This prompted us to evaluate the potential role of glucocorticoids as coregulators with insulin of glucose transporter expression using 3T3-F442A adipose cells and primary cultured rat adipocytes. In both systems, insulin increased and dexamethasone decreased GLUT1 messenger RNA (mRNA) and protein, an effect inhibited by the glucocorticoid antagonist RU 38486. When the two hormones were added together, the effect of dexamethasone was dominant in 3T3-F442A cells, but was totally antagonized in rat adipocytes. Moreover, in rat adipocytes, the GLUT1 gene transcription rate (run-on) was identical in the absence or presence of the two hormones. With regard to GLUT4 expression, neither insulin nor dexamethasone alone had any significant effect after 2 days of treatment. In contrast, the combined hormones markedly increased GLUT4 mRNA (+550% in rat adipocytes; +130% in 3T3-F442A cells) and protein (+164% in rat adipocytes; +79% in 3T3-F442A cells) with a 24- to 48-h delay after mRNA induction. Studies of the molecular mechanism(s) showed that exposure of rat adipocytes to dexamethasone plus insulin did not affect GLUT4 mRNA stability, but increased the GLUT4 gene transcription rate 3-fold. Transient transfections of rat adipocytes with the 5'-flanking 2.2-kilobase sequence of the rat GLUT4 gene fused to luciferase demonstrated that promoter activity was unchanged by insulin, increased 50% by dexamethasone, and increased 3-fold in the presence of both. These data show that insulin elicits an increase in GLUT4 gene expression provided glucocorticoids are present. Our results indicate that the synergism between insulin and glucocorticoids on GLUT4 gene transcription is mediated through GLUT4 promoter activation.
胰岛素对脂肪细胞中GLUT4表达的触发作用在体内一直被观察到,而GLUT1则基本不受影响。然而,在培养的大鼠脂肪细胞中,胰岛素增加GLUT1但未能增加GLUT4,这表明体内还涉及其他因素。这促使我们使用3T3-F442A脂肪细胞和原代培养的大鼠脂肪细胞来评估糖皮质激素作为葡萄糖转运蛋白表达的胰岛素共调节因子的潜在作用。在这两种系统中,胰岛素增加而地塞米松降低GLUT1信使核糖核酸(mRNA)和蛋白质,糖皮质激素拮抗剂RU 38486可抑制这种作用。当两种激素一起添加时,地塞米松的作用在3T3-F442A细胞中占主导,但在大鼠脂肪细胞中被完全拮抗。此外,在大鼠脂肪细胞中,无论有无这两种激素,GLUT1基因转录率(连续转录分析)都是相同的。关于GLUT4表达,单独使用胰岛素或地塞米松处理2天后均无任何显著影响。相反,联合使用激素显著增加GLUT4 mRNA(大鼠脂肪细胞中增加550%;3T3-F442A细胞中增加130%)和蛋白质(大鼠脂肪细胞中增加164%;3T3-F442A细胞中增加79%),mRNA诱导后有24至48小时的延迟。分子机制研究表明,将大鼠脂肪细胞暴露于地塞米松加胰岛素中不会影响GLUT4 mRNA稳定性,但会使GLUT4基因转录率增加3倍。用与荧光素酶融合的大鼠GLUT4基因5'侧翼2.2千碱基序列对大鼠脂肪细胞进行瞬时转染表明,胰岛素对启动子活性无影响,地塞米松使其增加50%,两者同时存在时增加3倍。这些数据表明,在有糖皮质激素存在的情况下,胰岛素会引起GLUT4基因表达增加。我们的结果表明,胰岛素和糖皮质激素对GLUT4基因转录的协同作用是通过GLUT4启动子激活介导的。